200 related articles for article (PubMed ID: 18394008)
1. Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections.
Kanazawa T; Uchihara T; Takahashi A; Nakamura A; Orimo S; Mizusawa H
Brain Pathol; 2008 Jul; 18(3):415-22. PubMed ID: 18394008
[TBL] [Abstract][Full Text] [Related]
2. Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals.
Kanazawa T; Adachi E; Orimo S; Nakamura A; Mizusawa H; Uchihara T
Brain Pathol; 2012 Jan; 22(1):67-78. PubMed ID: 21672073
[TBL] [Abstract][Full Text] [Related]
3. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
[TBL] [Abstract][Full Text] [Related]
4. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
[TBL] [Abstract][Full Text] [Related]
5. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
6. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
[TBL] [Abstract][Full Text] [Related]
7. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
[TBL] [Abstract][Full Text] [Related]
8. Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62.
Kuusisto E; Parkkinen L; Alafuzoff I
J Neuropathol Exp Neurol; 2003 Dec; 62(12):1241-53. PubMed ID: 14692700
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red.
Sakamoto M; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Mizusawa H; Hirai S
Exp Neurol; 2002 Sep; 177(1):88-94. PubMed ID: 12429213
[TBL] [Abstract][Full Text] [Related]
10. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
11. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.
Arima K; Uéda K; Sunohara N; Hirai S; Izumiyama Y; Tonozuka-Uehara H; Kawai M
Brain Res; 1998 Oct; 808(1):93-100. PubMed ID: 9795161
[TBL] [Abstract][Full Text] [Related]
12. Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus.
Shan L; Liu CQ; Balesar R; Hofman MA; Bao AM; Swaab DF
Neurobiol Aging; 2012 Jul; 33(7):1343-4. PubMed ID: 21371786
[TBL] [Abstract][Full Text] [Related]
13. Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease.
Gai WP; Blumbergs PC; Blessing WW
Acta Neuropathol; 1996; 91(1):78-81. PubMed ID: 8773150
[TBL] [Abstract][Full Text] [Related]
14. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
[TBL] [Abstract][Full Text] [Related]
15. Modeling Lewy pathology propagation in Parkinson's disease.
Luk KC; Lee VM
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S85-7. PubMed ID: 24262196
[TBL] [Abstract][Full Text] [Related]
16. [Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].
Wakabayashi K
Rinsho Shinkeigaku; 2008 Nov; 48(11):981-3. PubMed ID: 19198138
[TBL] [Abstract][Full Text] [Related]
17. Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson's Disease and Multiple System Atrophy.
Sonustun B; Altay MF; Strand C; Ebanks K; Hondhamuni G; Warner TT; Lashuel HA; Bandopadhyay R
Cells; 2022 Mar; 11(5):. PubMed ID: 35269528
[TBL] [Abstract][Full Text] [Related]
18. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.
Wakabayashi K; Tanji K; Mori F; Takahashi H
Neuropathology; 2007 Oct; 27(5):494-506. PubMed ID: 18018486
[TBL] [Abstract][Full Text] [Related]
19. The Lewy body in Parkinson's disease and related neurodegenerative disorders.
Wakabayashi K; Tanji K; Odagiri S; Miki Y; Mori F; Takahashi H
Mol Neurobiol; 2013 Apr; 47(2):495-508. PubMed ID: 22622968
[TBL] [Abstract][Full Text] [Related]
20. [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K; Takahashi H
Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
